Takamitsu Watanabe, MD/PhD

2009-2013 The University of Tokyo, Bunkyō-ku, Tōkyō-to, Japan 
 2013-2018 University College London, London, United Kingdom 
 2018-2020 Center for Brain Science RIKEN 
 2020- The University of Tokyo, International Research Center for Neurointelligence 
"Takamitsu Watanabe"
Mean distance: 13.66 (cluster 29)


Sign in to add mentor
Yasushi Miyashita grad student 2009-2013 University of Tokyo
Geraint Rees post-doc 2013-2018 UCL
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Setsuie R, Tamura K, Miyamoto K, et al. (2020) Off-Peak 594-nm Light Surpasses On-Peak 532-nm Light in Silencing Distant ArchT-Expressing Neurons In Vivo. Iscience. 23: 101276
Watanabe T, Lawson RP, Walldén YSE, et al. (2019) A neuroanatomical substrate linking perceptual stability to cognitive rigidity in autism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Watanabe T, Rees G, Masuda N. (2019) Atypical intrinsic neural timescale in autism. Elife. 8
Benner S, Aoki Y, Watanabe T, et al. (2018) Neurochemical evidence for differential effects of acute and repeated oxytocin administration. Molecular Psychiatry
Ezaki T, Sakaki M, Watanabe T, et al. (2018) Age-related changes in the ease of dynamical transitions in human brain activity. Human Brain Mapping
Watanabe T, Rees G, Masuda N. (2018) Author response: Atypical intrinsic neural timescale in autism Elife
Watanabe T, Rees G. (2017) Brain network dynamics in high-functioning individuals with autism. Nature Communications. 8: 16048
Watanabe T, Rees G. (2016) Anatomical imbalance between cortical networks in autism. Scientific Reports. 6: 31114
Ueno H, Kobayashi H, Konishi T, et al. (2016) Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan International Journal of Clinical Oncology. 1-10
Takashima T, Mukai H, Hara F, et al. (2015) Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial. The Lancet. Oncology
See more...